In This Section
CTN Research Committee
Committee Charges
The CTN was formed in 2009 to assist pharma with the use of molecular imaging in their trials. At the time, there were almost no company sponsored trials for the development of PET imaging agents. Following the implementation of CFR Part 212 by FDA, there has been an explosion of radiopharmaceutical trials for novel agents. CTN is often asked to assist with the science in conducting these Phase 1, 2, and 3 trials. CTN and the LLC have worked with 18 companies, on 20 imaging or therapy compounds labeled with 6 different isotopes. At this time, CTN needs the support of a diverse group of researchers – physicians, chemists, and physicists – each with special capability or experience, to assist in the work of CTN. The group is anticipated to serve as a pipeline for future CTN Leadership positions.
Charges:
- Assist in the development and maintenance of the Image-based Training Library
- Support the work of the CTN activities including educational sessions
- Support the work of NMCTG, LLC
- Support the activities and goals of the Research & Discovery Domain
- Provide a succession pipeline for CTN leadership positions
Committee Members
| Jonathan McConathy, MD, PhD | Co-Chairperson |
| Peter J.H. Scott, PhD, FSNMMI | Co-Chairperson |
| Jason S. Lewis, PhD, FSNMMI | Board Liaison |
| Corrine Bienat | Committee Member |
| Steve Y. Cho, MD | Committee Member |
| Margaret E. Daube-Witherspoon, PhD | Committee Member |
| Stephen A. Graves, PhD, DABR | Committee Member |
| Thomas A. Hope, MD | Committee Member |
| Andrei H. Iagaru, MD, FACNM | Committee Member |
| Geoffrey B. Johnson, MD, PhD | Committee Member |
| Mary Ellen I. Koran, MD, PhD | Committee Member |
| Suzanne E. Lapi, PhD, FSNMMI | Committee Member |
| Courtney A. Lawhn Heath, MD | Committee Member |
| Osama R. Mawlawi, PhD | Committee Member |
| Justin G. Peacock, MD, PhD | Committee Member |
| John J. Sunderland, PhD, MBA, FSNMMI | Committee Member |
| Jeffrey T. Yap, PhD | Committee Member |
| Bonnie Clarke | Liaison |